These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 8383579)

  • 41. Chalkley microvessel but not lymphatic vessel density correlates with axillary lymph node metastasis in primary breast cancers.
    Kanngurn S; Thongsuksai P; Chewatanakornkul S
    Asian Pac J Cancer Prev; 2013; 14(1):583-7. PubMed ID: 23534799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma.
    Bockmühl U; Theissig F; Dimmer V; Kunze KD
    Pathol Res Pract; 1991 May; 187(4):437-43. PubMed ID: 1652128
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
    Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
    J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
    Barth A; Craig PH; Silverstein MJ
    Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Casting-type calcifications with invasion and high-grade ductal carcinoma in situ: a more aggressive disease?
    Zunzunegui RG; Chung MA; Oruwari J; Golding D; Marchant DJ; Cady B
    Arch Surg; 2003 May; 138(5):537-40. PubMed ID: 12742959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.
    Sahin AA; Ro J; Ro JY; Blick MB; el-Naggar AK; Ordonez NG; Fritsche HA; Smith TL; Hortobagyi GN; Ayala AG
    Cancer; 1991 Aug; 68(3):549-57. PubMed ID: 1648433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up.
    Lara JF; Young SM; Velilla RE; Santoro EJ; Templeton SF
    Cancer; 2003 Nov; 98(10):2105-13. PubMed ID: 14601079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of early relapse and shortened survival in patients with breast cancer by proliferating cell nuclear antigen score.
    Tahan SR; Neuberg DS; Dieffenbach A; Yacoub L
    Cancer; 1993 Jun; 71(11):3552-9. PubMed ID: 8098267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of the in situ component in 389 infiltrating ductal breast carcinomas.
    Carabias-Meseguer P; Zapardiel I; Cusidó-Gimferrer M; Godoy-Tundidor S; Tresserra-Casas F; Rodriguez-García I; Fábregas-Xauradó R; Xercavins-Montosa J
    Breast Cancer; 2013 Jul; 20(3):213-7. PubMed ID: 22271067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prognostic factors in breast cancer].
    Georgescu R; Coroş MF; Stolnicu S; Podeanu D; Sorlea S; Roşca A; Copotoiu C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):262-7. PubMed ID: 23077906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor size as predictor of microinvasion, invasion, and axillary metastasis in ductal carcinoma in situ.
    Maffuz A; Barroso-Bravo S; Nájera I; Zarco G; Alvarado-Cabrero I; Rodríguez-Cuevas SA
    J Exp Clin Cancer Res; 2006 Jun; 25(2):223-7. PubMed ID: 16918134
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Solid variant of mammary adenoid cystic carcinoma with basaloid features: a study of nine cases.
    Shin SJ; Rosen PP
    Am J Surg Pathol; 2002 Apr; 26(4):413-20. PubMed ID: 11914618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship between existence of lymphatic invasion in peritumoral breast tissue and presence of axillary lymph node metastasis in invasive ductal carcinoma of the breast.
    Kurosumi M; Suemasu K; Tabei T; Inoue K; Matsumoto H; Sugamata N; Higashi Y
    Oncol Rep; 2001; 8(5):1051-5. PubMed ID: 11496315
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.
    Le Doussal V; Tubiana-Hulin M; Friedman S; Hacene K; Spyratos F; Brunet M
    Cancer; 1989 Nov; 64(9):1914-21. PubMed ID: 2551477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intramammary lymph nodes.
    Egan RL; McSweeney MB
    Cancer; 1983 May; 51(10):1838-42. PubMed ID: 6299498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular dyscohesion in fine-needle aspiration of breast carcinoma. Prognostic indicator for axillary lymph node metastases?
    Schiller AB; Tadros TS; Birdsong GG; Grossl NA
    Am J Clin Pathol; 2001 Feb; 115(2):219-23. PubMed ID: 11211610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extensive retraction artifact correlates with lymphatic invasion and nodal metastasis and predicts poor outcome in early stage breast carcinoma.
    Acs G; Dumoff KL; Solin LJ; Pasha T; Xu X; Zhang PJ
    Am J Surg Pathol; 2007 Jan; 31(1):129-40. PubMed ID: 17197929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of additional lymph node involvement in breast cancer patients with positive sentinel lymph nodes.
    Pohlodek K; Bozikova S; Meciarova I; Mucha V; Bartova M; Ondrias F
    Neoplasma; 2016; 63(3):427-34. PubMed ID: 26925789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.